Brief: Sedana Medical Adjusts, Clarifies Long-Term Financial Targets

Sedana Medical AB (publ)

08/11/2019 15:08

Nov 8 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL ADJUSTS AND CLARIFIES ITS LONG-TERM FINANCIAL TARGETS
    * ANNOUNCED THAT COMPANY WILL NO LONGER COMMUNICATE A PROFIT TARGET FOR PERIOD UNTIL
REGISTRATION
OF ISOCONDA IN EUROPE
    * SALES TARGET OF SEK 500 MILLION THREE YEARS AFTER EUROPEAN REGISTRATION ONLY APPLIES TO
SALES IN
EUROPE
    * REGISTRATION WORK FOR ANACONDA AND ISOCONDA HAS BEGUN IN UNITED STATES
    * STILL EXPECTS AN EBITDA MARGIN OF ABOUT 40 PERCENT THREE YEARS AFTER REGISTRATION OF
ISOCONDA IN
EUROPE
    * WORK OF BUILDING LARGER MARKETING, SALES AND MEDICAL ORGANIZATIONS IN EUROPE, BUT ALSO
OUTSIDE
EUROPE, HAS BEEN INTENSIFIED AND SEDANA MEDICAL NO LONGER SETS ANY PROFIT TARGETS FOR TIME
BEFORE REGISTRATION
    * IF EVERYTHING DEVELOPS ACCORDING TO PLAN, COMPANY EXPECTS REGISTRATION OF ISOCONDA IN
EUROPE TO
TAKE PLACE DURING SECOND HALF OF 2021

Source text for Eikon:  ID:nWkr79xt3j 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))